SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Novo Nordisk lifts outlook on obesity drug sales

Novo Nordisk raised its outlook for obesity drug sales.

NVO
SquawkNews Desk 1 updates Updated Nov 04, 2026, 09:30 AM UTC

Story updates

09:30:29 AM UTC
SquawkNews
04:26 AM EST, 11/04/2026 (MT Newswires) -- Novo Nordisk (NVO) reported Q3 net sales of 79.20 billion

Related stories

Mitsubishi, Mitsui Raise Fiscal 2026 Profit Forecasts to Records Mitsubishi Corp and Mitsui & Co raised their net profit forecasts for the fiscal year ending next March to record levels, citing higher first-half earnings as energy and metals pri M impact | EARNINGS | Nov 04, 2026, 10:16 AM UTC Coloplast Revises Annual Growth Ambition to 5–7% Through 2030 M impact | EARNINGS | Nov 04, 2026, 10:12 AM UTC Anand Rayons Reports September-Quarter Revenue of 1.45 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 10:11 AM UTC Smith & Nephew Ends J&J Orthopedics Talks, Cuts 2026 Revenue Outlook Smith & Nephew confirmed that merger talks with Johnson & Johnson’s orthopedics unit have ended and cut its 2026 revenue outlook. M impact | EARNINGS | Nov 04, 2026, 10:07 AM UTC Karrie International Expects First-Half Attributable Profit to Rise About 100% M impact | EARNINGS | Nov 04, 2026, 10:06 AM UTC Lenskart Reports September-Quarter Revenue of 28.45 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 10:06 AM UTC